The Alliance for Longevity Initiatives

06/10/2026

Our H-SPAN Summit DC is just around the corner. This year, we’re building on last year’s conversation about cross-agency alignment in funding and regulatory frameworks for longevity.

We are thrilled to close Day 2 of the Summit with a landmark session: “Building the Framework: Policy Levers for Longevity Innovation.” For the first time, senior administration leaders and Members of Congress will join in a singular forum to discuss current federal initiatives and legislative levers that set out to make healthy longevity a national priority and achieve a true "longevity dividend."

Featured speakers for this policy-focused second day include:
• Dr. Mehmet Oz (Tentative), Administrator of the Centers for Medicare & Medicaid Services (CMS)
• Lowell M. Zeta, Acting Chief of Staff and Deputy Commissioner for Strategic Initiatives, U.S. Food and Drug Administration (FDA)
• Dr. Alicia Jackson, Director of the Advanced Research Projects Agency for Health (ARPA-H)
• Congressman Kevin Mullin (CA-14), Representative of the Bay Area Longevity Biotech Ecosystem
• Congressman Jim McGovern (MA-2), Ranking Member of the House Rules Committee and Champion for Nutrition and Healthy Aging Policy
• Congressman Paul D. Tonko (NY-20), Co-chair of the Congressional Longevity Science Caucus

06/09/2026

What an unforgettable day! Yesterday marked a monumental win for the geroscience field and the longevity industry. California Senate Resolution 104 passed the floor with a unanimous 35-0 vote!

Joining the presentation on the Senate floor were Dylan Livingston (Founder and CEO of A4LI), Sonia Arrison (Chair of the A4LI Board), Dr. Joon Yun, Remy Gross, and Sean Curran.

We are beyond grateful to Senator Josh Becker and Senator Akilah Weber Pierson for introducing this historic resolution. The Alliance for Longevity Initiatives is excited to get to work and collaborate with LeadingAGE California, California Life Sciences, and the California Chronic Care Coalition on forward-thinking policies that promote aging biology research and public-private collaboration. By integrating longevity strategies into California's public health framework, SR-104 will optimize healthspans while driving significant long-term cost savings for the state!

06/04/2026

HB 1735 has passed the New Hampshire Senate.

The bill was amended during the legislative process, but its passage reflects growing recognition that patients and innovators deserve greater flexibility when pursuing promising longevity therapies.

"The final bill is more limited than we originally hoped for, but it's encouraging to see states like New Hampshire continue engaging with these issues,” said Dylan V. Livingston, Founder and CEO of the Alliance for Longevity Initiatives (A4LI). “The reality is that patients are looking for more options, and policymakers across the country are increasingly willing to have that conversation."

We are grateful to the many New Hampshire leaders who championed HB 1735, including Governor Kelly Ayotte and Speaker of the New Hampshire House of Representatives Sherman Packard. We also extend our thanks to the stakeholders, advocates, and volunteers who dedicated their time and energy to supporting the legislation and advancing the conversation around patient access and medical innovation.

06/02/2026

Next week, A4LI and a strong representation of academic and biotechnology leaders in longevity will join CA Senator Josh Becker as he presents Senate Resolution 104.

SR 104 advocates for a fundamental shift in how California approaches public health and fiscal planning regarding the state's aging population. The resolution encourages state health and aging departments to integrate geroscience into public health programming while fostering collaboration among academia, health plans, and biotechnology firms to pilot innovative longevity medicines and gerotherapeutics.

This is an incredible milestone for California, the leading state for investment, talent, and innovation in the longevity science field!

Resolution Text: https://legiscan.com/CA/text/SR104/id/3426763

05/28/2026

The H-SPAN Summit D.C. is only ONE MONTH away!

Join us as we bring together researchers, policymakers, innovators, and advocates working to accelerate progress against age-related diseases and advance the future of medicine.

Registration and Agenda Here: a4li.org/h-span-summit-dc/

05/27/2026

A fantastic complement to our whitepaper, kudos! The math on our current funding allocation within the NIH simply does not add up, and only by Realigning For Impact can we bring research funding in line with what really kills us.

If The Longevity Initiative's report, or ours has convinced you, we urge you to sign the petition to get this issue in front of your representatives!

https://actionnetwork.org/petitions/realigning-for-impact-sign-on-to-support-our-cross-institute-aging-consortia-proposal-2?source=direct_link&

Read it here: https://thelongevityinitiative.org/2026/05/research-funding-deaths-ageing-a4li/

Cancer gets 80 times more funding per death than research into ageing.

05/26/2026

We’re heading back to AGE (American Aging Association) in Provo, Utah next week! Don’t miss Brenda Eap chairing “Bridging Discovery and Application: The Longevity Biotech Landscape” on June 3 (3:30–5:15 PM), featuring insights from Junevity, BioAge Labs, and Rubedo.

Learn more about it here: https://age.memberclicks.net/annual-meeting

05/22/2026

Thank you for highlighting the momentum we have been building since our inaugural event in 2024, Longevity.Technology! Incredible to see how far the conversation has moved from speculative science to serious national policy in just three years.

Read it here:

Policy, biotech and geroscience converge in DC as longevity science edges further into the American political mainstream.

05/21/2026

Hosting our Summit at Georgetown University’s Capitol Campus allows us to do so much more! We will have quick pitches, workshops, and a poster session for everyone to participate in!

Check out the full schedule and get your ticket today: https://a4li.org/h-span-summit-dc/

05/18/2026

The Alliance for Longevity Initiatives (A4LI) would like to provide an update regarding New Hampshire’s ongoing efforts to expand patient access to investigational medical treatments and strengthen the state’s position as a hub for biomedical innovation.

This week, legislative language from HB1734 and HB1735 was successfully attached to SB504 through the amendment process in the New Hampshire House of Representatives, keeping these reforms active as negotiations continue.

HB1734 would authorize the establishment of experimental treatment centers capable of offering eligible investigational therapies under state oversight, while HB1735 would expand New Hampshire’s Right to Try framework to include patients suffering from chronic and debilitating conditions

We would especially like to thank House Speaker Sherman Packard and Majority Leader Jason Osborne for their leadership and continued support. Together, these proposals continue New Hampshire’s emergence as one of the most forward-looking states in the country on medical innovation, patient autonomy, and access to next-generation therapies.

As the process continues, we encourage everyone to respectfully reach out to Senate President Sharon Carson, Senator Rochefort, and Senator Birdsell and urge them to support SB504 as amended during committee of conference negotiations.

We look forward to continuing to work with lawmakers, patients, advocates, and innovators as this effort progresses.